What you can't see, you can't manage. By making their medication inventories visible through an intelligent infrastructure, pharmacy leaders at St. Jude Children's Research Hospital and their teams improved patient care, workflow, compliance, and financial performance.
Hospitals are overwhelmed and understaffed. Automation technologies can help address some of these workforce challenges, but are only part of the equation. Learn more at our webinar on empowering clinicians.
The pressures of the last year have underscored the importance of the 340B program and its impact on hospital finances. Hospital leadership needs to understand why a dedicated 340B program manager is key to driving program success.
Archbold Health System is a leader in leveraging cloud-based data and predictive analytics to provide a holistic view of medication inventory management. In part two of our Omnicell Blog series, learn how Archbold found success through intelligence and why it is the future of medication management.
Pharmacy staffing shortages have been around since the 1980s. But the combination of pandemic burnout and other industries competing for talent is leading to increased turnover. Learn how a robust technology strategy can help your pharmacy address the labor challenges.
Pharmacists and other healthcare practitioners face many risks in the supply chain. Data is stored across different healthcare facilities, making it difficult for them to make decisions about inventory management since they often need to access this information manually before making any intelligent choices. Learn how Archbold Medical Center in Georgia used analytics to break down silos and improve patient safety across the continuum of care.
The Pharmacy and Medically Underserved Areas Enhancement Act is a bill that would grant pharmacists provider status under Medicare Part B to help address the worsening shortage of primary care physicians in America. Join Omnicell's Chief Clinical Officer James Stevenson for this critical discussion with pharmacy leaders during the virtual ASHP Midyear Meeting 2021.
A collaboration between Omnicell and Fresenius Kabi is helping U.S. health systems to manage controlled substances better, reduce diversion, and save nursing time through new pharmacy technology designed to enhance patient safety and efficiency.
After five major federal court decisions within a week, it's clear that there will be no quick resolution to the contract pharmacy battle. All five drug companies received a reprieve from having to restore 340B pricing in the contract pharmacy setting.
With anesthesia providers and pharmacies on the same page, patients can benefit from a seamless medication experience in an operating room. Closed-loop technology is crucial for both entities to succeed. Listen to the latest episode of the Future of Pharmacy Podcast to hear more.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.